19 เมษายน 2539 (TRANSLATION) Tor. For. 18 /2018 September 3, 2018 Subject : Clarification on the Company’s Operation Results for Q2/2018 To : President of the Stock Exchange of Thailand As Far East
company still has foreign exchange gains compared to US dollars. (Which is the main trading currency of the company) Cost of Sales for Q3 / 2020 and Q3 / 2019 was 347.60 million baht and 357.94 million baht
also had a loss from the exchange rate compared to the US dollar (the company's main trading currency). Please be informed Yours sincerely, (Ms. Sineemas Sotpiparpnukul) Chief Executive Officer
represents decreasing of 6 Million Baht (122%) from Q3/2017. The main cause for the lower net profit are occurred from increasing of selling and administration expenses, and loss on foreign exchange rates
จดหมายชี้แจงQ161e May 14, 2018 The Managing Director The Stock Exchange of Thailand Subject : Management Discussion and Analysis for three month Ending 31 March 2018 Summary of the 1 st Quarter
Exchange of Thailand The operating performance for three-month period ended 31 March 2017 of Mahachai Hospital Public Company Limited was highlighted as follow: Company performance for three-month period
February 29, 2008 14 May 2018 Subject : Management discussion and analysis of financial statement for three-month period ended 31 March 2018 Attention : Director and Manager The Stock Exchange of
online systems. and the company still has foreign exchange gains compared to US dollars. (Which is the main trading currency of the company) Cost of Sales for Q2 / 2020 and Q2 / 2019 was 400.98 million